TransMedics to Present at Upcoming June Investor Conferences

Rhea-AI Summary

TransMedics (Nasdaq: TMDX), a medical technology company focused on organ transplant therapy, has announced its participation in two major investor conferences in June 2025. The company will present at the William Blair 45th Annual Growth Stock Conference in Chicago on June 3 at 5:00 p.m. EST and participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on June 9 at 8:00 a.m. EST. Both presentations will be available via webcast on TransMedics' investor relations website.

ANDOVER, Mass., May 20, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the company will be participating in two upcoming investor conferences. TransMedics management is scheduled to present at the William Blair 45^th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 5:00 p.m. EST and participate in a fireside chat at the Goldman Sachs 46^th Annual Global Healthcare Conference in Miami on Monday, June 9, 2025, at 8:00 a.m. EST.

Event: William Blair 45^th Annual Growth Stock Conference
Date: Tuesday, June 3, 2025
Time: 5:00 p.m. EST

Event: Goldman Sachs 46^th Annual Global Healthcare Conference
Date: Monday, June 9, 2025
Time: 8:00 a.m. EST

A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-june-investor-conferences-302460862.html

SOURCE TransMedics Group, Inc.

FAQ

When and where will TransMedics (TMDX) present at the William Blair Conference in 2025?

TransMedics will present at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 5:00 p.m. EST.

What time is TransMedics' (TMDX) presentation at the Goldman Sachs Healthcare Conference 2025?

TransMedics will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025, at 8:00 a.m. EST.

How can investors access TransMedics' (TMDX) conference presentations?

Investors can access live and archived webcasts of the presentations through the 'Investors' section of TransMedics' website at https://investors.transmedics.com/.

What type of company is TransMedics (TMDX)?

TransMedics is a medical technology company that develops therapy for patients with end-stage lung, heart, and liver failure through organ transplant solutions.